HHS Finalizes Health Data, Technology, and Interoperability Rules

The final rule includes provisions that accelerate electronic prior authorizations by enabling providers to electronically submit prior authorizations using certified platforms, resulting in faster care authorization decisions and more transparency for patients and providers. In addition, the final rule will improve drug cost transparency by enabling prescribers to compare drug prices during care encounters in real time and identify lower cost alternatives available under a patient’s insurance coverage, particularly patients with prescription benefits under Medicare Part D.